According to sources, nine European nations have recognised the Serum Institute of India’s Covishield vaccine. The confirmation came on Thursday when the European Union launched the “Green Pass” programme, which would let travellers immunised with an approved set of vaccinations to travel inside the EU zone, including 27 countries. The nine nations’ acceptance is a “national” action by the states, not by the European Union, based in Brussels.
Austria, Germany, Slovenia, Greece, Iceland, Ireland, and Spain are among the EU Member States who have recognised Covishield as a legitimate vaccination. Aside from that, Estonia has confirmed that it will recognise all vaccinations authorised by the Government of India for Indians travelling to Estonia. Switzerland, which is not a member of the EU, also accepts Covishield as a Schengen state.
Germany’s ambassador, Walter J. Lindner, backed the action, saying, “Confirming that a double injection of Covishield is completely recognised by Germany as sufficient proof of anti-COVID immunisation.” Germany, on the other hand, has a travel restriction in place for Indians since India has been designated as a “virus variant nation.”
“However, this (confirmation) does not change current travel or visa limitations for travellers from regions of concern/virus variant areas,” Mr Lindner clarified the German perspective on travel from India.
The approval by the nine European countries came on the same day that the EU announced the “Green Pass,” which is intended for travel inside the EU’s 27 member states. The clearance by the nine nations is unlikely to result in automatic clearance of Covishield as an analogue to the “Green Pass” that recognises Pfizer/Community, BioNTech’s Moderna’s Spikevax, Oxford-Vaxzevria, AstraZeneca’s and Johnson & Johnson’s Janssen.
The European Medicines Agency (EMA), which produced the approved list, has yet to adopt Covishield, which is based on an AstraZeneca formula.
The approval of Covishield by nine European countries demonstrated that the certain EU Member States are developing strategies to meet their health and international needs. Air France, for example, has announced that Indian travellers who have taken EMA-approved dosages (Pfizer-Comirnaty, BioNTech’s Moderna’s Spikevax, Oxford-Vaxzevria, AstraZeneca’s and Johnson & Johnson’s Janssen) must undergo a week of “mandatory quarantine.”
“These passengers must present a Covid-19 vaccination certificate demonstrating that at least 4 weeks have passed since the first dose of Johnson & Johnson vaccine, or 2 weeks have passed since the second dose of the Pfizer-BioNTech, AstraZeneca, or Moderna vaccine, or since the first dose of these vaccines if the passenger has proof that they have previously been infected with COVID-19,” said the statement.
Continue Reading on Spot Latest